Current location - Trademark Inquiry Complete Network - Futures platform - Can Southern Big Data 100 survive?
Can Southern Big Data 100 survive?
Hello, I will answer this question for you next.

According to the data, the Southern Big Data 100 index securities investment fund is currently rising by 1.73%. So you're still alive.

The financial fund 65438+1October 22nd Southern Big Data 100 Index Securities Investment Fund (hereinafter referred to as Southern Big Data 100 Index A, code 00113) announced the latest net value, up/kloc. The unit net value of the Fund is 1.0063 yuan, and the cumulative net value is 1.0063 yuan.

Southern Big Data 100 Index Securities Investment Fund was established on 20 15-04-24, and its performance benchmark is "Big Data 100 Index * 95.00%+ bank demand deposit *5.00%". The fund has earned 0.63% since its establishment, 50.96% this year, 6.68% last month, 56.45% in the latest year and 15.99% in the last three years. The similar ranking of the Fund in the past year (208/745) and since its establishment (833/9 1 1).

According to the ranking data of fixed investment of wealth management funds, the income from fixed investment of funds in the last year was 365,438+0.38%, that from fixed investment of funds in the last two years was 45.22%, that from fixed investment of funds in the last three years was 40.66,438+0%, and that from fixed investment of funds in the last five years was 30.49%. (Click here to view the ranking of fixed investment)

The fund manager is Qian Houxiang, who started to manage the fund on June 28th, 20 19, and earned 59. 15% during his tenure.

The latest periodic report shows that the top ten positions of the fund are Chongqing Beer (shareholding ratio 1.08%), Xinjie Electric (shareholding ratio 1.06%), Hualan Bio (shareholding ratio 1.06%) and Longji (shareholding ratio1.

In the last reporting period of the latest reporting period, the top ten positions of the fund were Intel Technology (1.79%), Shengtian Network (1.32%), Baolaite (1.28%) and Lance Technology (1. Dali Technology (shareholding ratio 1.08%), Oriental Fortune (shareholding ratio 1.06%), Daan Gene (shareholding ratio 1.04%), Beida Pharmaceutical (shareholding ratio 1.04%), and Sheng Bang (.

Analysis of Fund Investment Strategy and Operation during the Reporting Period

In the third quarter of 2002/kloc-0, the fund's investment was mainly based on quantitative stock selection model, supplemented by the holding of dragon futures. In the part of quantitative stock selection, we use the enhancement strategies of CSI 500 Index, CSI 300 Index, quantitative fundamentals and event-driven models. Using multi-strategy fusion model to invest in stocks. Futures long position: holding a small number of CSI 500 futures long positions.

202 1 The overall performance of the market in the first three quarters was optimistic, showing the response to the economic situation and future economic expectations; Judging from the global economic situation and the impact of the epidemic, China's repair level has always maintained a relatively leading position in the world after the economic epidemic, and the overall situation has continued to improve; In the past six months, the securities market has been active, especially in the industries around the epidemic and internal circulation. We are cautiously optimistic about the overall market performance in the future, and the industry allocation is also carefully invested around the tone of "internal circulation" and epidemic recovery.

As of the end of the reporting period, the net value of share A of the Fund was 0.9433 yuan. During the reporting period, the growth rate of net share was 1 1.02%, and the benchmark growth rate of performance in the same period was 10.73%. The net share value of Fund C is 0.9308 yuan. During the reporting period, the growth rate of net share was 65,438+00.92%, and the benchmark growth rate of performance in the same period was 65,438+00.73%.